₹ 5.13 -0.28 (-5.18%)
- NSE
- BSE
Overview
- BSE Code 533317
- NSE Symbol OMKARCHEM
- ISIN Demat INE474L01016
- Book Value (₹) -83.12
- Face Value (₹) 10.00
- Market Cap (₹ Cr.) 11.73
- P/E (TTM) 0.00
- EPS (TTM) 0.00
- Div Yield (%) 0.00
Performance
Corporate Actions
Omkar Speciality Chemicals Limited - Corporate Insolvency Resolution Process
Dec 25, 2024Omkar Speciality Chemicals Limited has informed the Exchange about Corporate Insolvency Resolution Process, Post Facto intimation of 12th CoC meeting held on 23rd December, 2024.
About Omkar Speciality Chemicals Ltd
The Company was originally incorporated as Omkar Speciality Chemicals Private Limited on February 24, 2005. It was converted into a public limited company under the name Omkar Speciality Chemicals Limited on March 18, 2010. The company assumed full control of the business of Omkar Chemicals, a proprietary concern (proprietor Mr. Pravin Herlekar) in June, 2005. Omkar Chemicals was formed in the year 1983 with capacity of 6 MT per annum for manufacture of molybdenum derivatives. At the time of takeover in June, 2005, the installed capacity was 318 MT and the product range was cobalt, selenium & iodine derivatives in addition to molybdenum derivatives. During the year 2006-07, The Firm broadened its footprint the total installed capacity to 325 MT which was further increased to 375 MT during the year 2007-08. In March, 2009, the company created and deployed a new manufacturing facility at Badlapur (E), Thane, Maharashtra viz. Unit 2 with an installed capacity of 375 MT. With the setting up of Unit 2, the companies total installed capacity increased to 750 MT. The Company has recently created and deployed a new manufacturing facility at Badlapur, Thane, Maharashtra viz. Unit 3 with an installed capacity of 200 MT through internal accruals. The commercial production at Unit 3 is likely to start in the month of March, 2011. With the created and deployed of Unit 3, the companies total installed capacity stands increased to 950 MT. Pursuant to a Share Purchase Agreement dated May 14, 2010 between the Company and the shareholders of Rishichem Research Limited, the company purchased 1078 Equity Shares of Rishichem Research Limited thereby holding 99.82% and making it the company wholly owned Subsidiary.
In August 2010, the company received ISO-9001-2008 certification for the Unit 2 in respect of quality management systems.
In 2011, the company created and deployed a research center at Company`s Unit No. IV
In 2012, the company forayed into pharmaceutical business with its recent acquisition of LASA Laboratory Private Limited located at Mahad.
In 2013, the company executed a strategic acquisition of the rights of the plot no. W-93(A), admeasuring about 720 sq,mtrs situated at MIDC, Badlapur (East), Thane 421503, which earlier belonged to M/s Desh Chemicals Pvt Ltd.
In 2015, the company has has Commissioned the Company`s New Facility at Chiplun. During the year, the company baged concrete indents worth Rs 100 crore".
Founded | : 2005 |
Chairman | : Pravin S Herlekar |
Managing Director | : Pravin S Herlekar |
Address | : B-34 MIDC, Badlapur (E), Thane, Maharashtra, 421503, |
HO Tel | : 91-251-2690651/2697340/48/49 |
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)